All manuscripts submitted to the Journal of Pharmacy Innovation and Practice (JAPRI) are subject to a plagiarism screening process before entering the peer review stage. Plagiarism in any form is strictly unacceptable in JAPRI.

The journal uses Turnitin software to check the originality of submissions. Manuscripts with a similarity index exceeding 20% (excluding references and common phrases) may be returned to the author(s) for revision or rejected outright.

By submitting a manuscript to JAPRI, authors acknowledge and agree to this plagiarism screening policy as part of the journal’s commitment to maintaining academic integrity and publication ethics.